Five Prime Therapeutics, Inc. Contract Liability (Deferred Revenue)
Five Prime Therapeutics, Inc. had Contract Liability (Deferred Revenue) of $1.25 million as of 2020-09-30, per its 10-Q filed 2020-11-03.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Deferred Revenue, Current
us-gaap:ContractWithCustomerLiabilityCurrent · last filed 2021-03-22
- 2020-09-30: Contract with Customer, Liability, Current $1.25M.
- 2020-06-30: Contract with Customer, Liability, Current $548.00K.
- 2020-03-31: Contract with Customer, Liability, Current $119.00K.
- 2019-12-31: Contract with Customer, Liability, Current $1.30M.
| Period end | Contract with Customer, Liability, Current |
|---|---|
| 2020-09-30 | $1.25M 10-Q · filed 2020-11-03 |
| 2020-06-30 | $548.00K 10-Q · filed 2020-08-06 |
| 2020-03-31 | $119.00K 10-Q · filed 2020-05-07 |
| 2019-12-31 | $1.30M 10-K · filed 2021-03-22 |
| 2019-09-30 | $2.15M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $2.91M 10-Q · filed 2019-08-08 |
| 2018-12-31 | $1.43M 10-K · filed 2020-02-27 |
| 2018-09-30 | $1.69M 10-Q · filed 2018-11-06 |
| 2017-12-31 | $12.71M 10-K · filed 2019-02-26 |